Aura Biosciences, Inc. (AURA)
↓ Download CSVKey ratios (FY2025)
-77.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$112.79M | -$96.12M | -$84.99M | -$60.30M | -$35.25M | -$22.21M | — |
| Net Income | -$106.19M | -$86.92M | -$76.41M | -$58.76M | -$35.25M | -$22.21M | — |
| EPS (Diluted) | $-1.76 | $-1.75 | $-1.93 | $-1.96 | $-8.95 | — | — |
| Total Assets | $169.43M | $182.50M | $255.07M | $223.94M | $160.03M | $22.10M | — |
| Total Liabilities | $32.52M | $30.53M | $29.23M | $28.35M | $7.71M | $2.74M | — |
| Shareholders' Equity | $136.91M | $151.97M | $225.85M | $195.58M | $152.31M | -$108.71M | -$87.41M |
| Cash & Equivalents | $59.52M | $31.69M | $41.06M | $121.58M | $149.06M | $17.39M | — |
| Operating Cash Flow | -$84.74M | -$79.81M | -$63.85M | -$54.60M | -$32.41M | -$24.32M | — |
| Capital Expenditures | $447.0K | $1.25M | $709.0K | $1.09M | $2.12M | $771.0K | — |
| Shares Outstanding | 63.59M | 50.00M | 49.35M | 37.77M | 29.21M | 381.1K | — |